Malvern Instruments to acquire US business
MALVERN Instruments has entered into an agreement with GE Healthcare Life Sciences to acquire the company’s MicroCal microcalorimetry business.
Financial terms have not been disclosed.
The acquisition, which is subject to regulatory approvals, is expected to complete in the third quarter of 2014.
MicroCal has a 30-year history of developing and supplying easy-to-use microcalorimeters. These systems are used extensively to study proteins and other biomolecules in drug discovery and development.
The acquisition of MicroCal will further strengthen The Malvern-based firm’s portfolio of analytical solutions for customers in core pharmaceutical and biopharmaceutical markets.
MicroCal will retain its key location in Northampton, Massachusetts.
Paul Walker, managing director of Malvern Instruments, said: “Microcalorimetry is now an essential tool that is used at almost every stage of the drug discovery, development and formulation process.
“MicroCal is an established technology leader in the field. MicroCal products are an excellent fit with Malvern’s existing portfolio of measurement solutions for the pharmaceutical and biopharmaceutical industries.
“Their ability to deliver information about drug binding and protein stability is entirely complementary to Malvern’s current products and to those in development.
“This addition to our business will have an immediate impact on Malvern’s ability to provide a complete range of instrumentation solutions and support across life science research and development.”
